Medicare Enrolled
Dr. Dyanesh Bapu Ravindran, M.D
Hematology & Oncology · Redding, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ravindran from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ravindran?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ravindran
Dr. Dyanesh Bapu Ravindran is a hematology & oncology specialist in Redding, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Ravindran performed 18,244 Medicare services across 1,719 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ravindran received a total of $11,716 from 60 pharmaceutical and/or device companies across 342 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ravindran is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 24% volume in CA
$11,716 industry payments
Medicare Practice Summary
Medicare Utilization ↗18,244
Medicare services
Top 24% in CA for hematology & oncology
1,719
Unique beneficiaries
$18
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~960 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
9,180 | $0 | $1 |
| Pembrolizumab injection (Keytruda) | 3,402 | $44 | $70 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,164 | $75 | $149 |
| Injection, heparin sodium, (heparin lock flush), per 10 units | 760 | $0 | $1 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
537 | $0 | $2 |
| Injection, granisetron hydrochloride, 100 mcg | 450 | $0 | $4 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
380 | $1 | $3 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
258 | $48 | $94 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
224 | $15 | $80 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
184 | $8 | $20 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
172 | $1 | $5 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
171 | $8 | $40 |
| Albumin infusion, 25%, 20 ml This procedure involves the intravenous administration of a 20 ml dose of 25% human albumin solution. |
165 | $17 | $60 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
119 | $99 | $149 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
112 | $8 | $40 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
98 | $12 | $65 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
82 | $7 | $40 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
77 | $63 | $200 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
69 | $68 | $126 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
69 | $103 | $186 |
| New patient office visit, complex (60-74 min) | 59 | $145 | $284 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
58 | $13 | $64 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
51 | $1 | $8 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
46 | $131 | $400 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
40 | $6 | $30 |
| Liver function blood test panel | 33 | $8 | $30 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
33 | $13 | $50 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
31 | $28 | $100 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
28 | $1 | $8 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
27 | $10 | $60 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
25 | $142 | $368 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
24 | $64 | $184 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
23 | $37 | $160 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
22 | $19 | $60 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
19 | $88 | $169 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
19 | $1 | $7 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
17 | $15 | $80 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
16 | $14 | $60 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
53.4% high complexity
29.3% medium
17.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,716
Total received (2018-2024)
Avg $1,674/year across 7 years
Top 29% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
342
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,529 (72.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,541 (21.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$647 (5.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,936
2023
$2,672
2022
$896
2021
$209
2020
$191
2019
$209
2018
$2,604
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$388
Daiichi Sankyo Inc.
$361
AstraZeneca Pharmaceuticals LP
$303
PFIZER INC.
$301
Merck Sharp & Dohme LLC
$287
Celgene Corporation
$258
Lilly USA, LLC
$257
Novartis Pharmaceuticals Corporation
$256
Genentech USA, Inc.
$237
Takeda Pharmaceuticals U.S.A., Inc.
$188
Aveo Pharmaceuticals, Inc.
$166
Eisai Inc.
$152
GlaxoSmithKline, LLC.
$136
Karyopharm Therapeutics Inc.
$125
ABBVIE INC.
$122
US Oncology Corporate, Inc.
$102
SEAGEN INC.
$100
ADC Therapeutics America, Inc.
$100
Stemline Therapeutics Inc.
$98
Rigel Pharmaceuticals, Inc.
$98
Incyte Corporation
$92
SpringWorks Therapeutics, Inc.
$70
PharmaEssentia USA Corporation
$69
E.R. Squibb & Sons, L.L.C.
$67
Deciphera Pharmaceuticals Inc.
$60
GENZYME CORPORATION
$58
Alexion Pharmaceuticals, Inc.
$50
Gilead Sciences, Inc.
$44
SOBI, INC
$37
Ipsen Biopharmaceuticals, Inc
$32
Pharmacosmos Therapeutics Inc.
$31
TAIHO ONCOLOGY, INC.
$31
Coherus Biosciences Inc.
$30
BeiGene USA, Inc.
$29
Acrotech Biopharma Inc.
$28
Kyowa Kirin, Inc.
$26
Biocon Biologics Inc
$22
Sumitomo Pharma America, Inc.
$21
Verity Pharmaceuticals Inc.
$21
Bayer Healthcare Pharmaceuticals Inc.
$19
Spectrum Pharmaceuticals Inc.
$17
ARRAY BIOPHARMA INC
$16
Regeneron Healthcare Solutions, Inc.
$15
Mirati Therapeutics, Inc.
$15
Top 3 companies account for 21.3% of 2024 payments
All-time payments by company (2018-2024) ›
Heron Therapeutics, Inc.
$2,541
Janssen Biotech, Inc.
$904
PFIZER INC.
$595
Lilly USA, LLC
$541
AstraZeneca Pharmaceuticals LP
$523
Merck Sharp & Dohme LLC
$517
Daiichi Sankyo Inc.
$476
Novartis Pharmaceuticals Corporation
$383
E.R. Squibb & Sons, L.L.C.
$378
Incyte Corporation
$332
Celgene Corporation
$312
Takeda Pharmaceuticals U.S.A., Inc.
$295
Eisai Inc.
$289
Genentech USA, Inc.
$285
US Oncology Corporate, Inc.
$276
GlaxoSmithKline, LLC.
$179
Rigel Pharmaceuticals, Inc.
$178
Stemline Therapeutics Inc.
$168
Aveo Pharmaceuticals, Inc.
$166
ABBVIE INC.
$148
Seagen Inc.
$127
Karyopharm Therapeutics Inc.
$125
Astellas Pharma US Inc
$113
GENZYME CORPORATION
$109
SEAGEN INC.
$100
ADC Therapeutics America, Inc.
$100
PharmaEssentia USA Corporation
$94
Intuitive Surgical, Inc.
$92
BeiGene USA, Inc.
$84
Pharmacyclics LLC, an AbbVie Company
$77
Pharmacosmos Therapeutics Inc.
$76
Gilead Sciences, Inc.
$74
TAIHO ONCOLOGY, INC.
$73
Alexion Pharmaceuticals, Inc.
$72
SpringWorks Therapeutics, Inc.
$70
Pharmacyclics LLC, An AbbVie Company
$62
SOBI, INC
$62
Deciphera Pharmaceuticals Inc.
$60
Coherus Biosciences Inc.
$54
Amgen Inc.
$52
Sumitomo Pharma America, Inc.
$51
Regeneron Healthcare Solutions, Inc.
$46
Kite Pharma, Inc.
$46
SERVIER PHARMACEUTICALS LLC
$42
Mirati Therapeutics, Inc.
$34
Exelixis Inc.
$33
Ipsen Biopharmaceuticals, Inc
$32
Foundation Medicine, Inc.
$30
Acrotech Biopharma Inc.
$28
Apellis Pharmaceuticals, Inc.
$26
Kyowa Kirin, Inc.
$26
AVEO Pharmaceuticals, Inc.
$25
Biocon Biologics Inc
$22
Alnylam Pharmaceuticals Inc.
$21
Verity Pharmaceuticals Inc.
$21
Bayer Healthcare Pharmaceuticals Inc.
$19
Spectrum Pharmaceuticals Inc.
$17
ARRAY BIOPHARMA INC
$16
Acrotech Biopharma LLC
$14
Janssen Pharmaceuticals, Inc
$10
Top 3 companies account for 34.5% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AUGTYRO · Alecensa · BELEODAQ · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · CABOMETYX · CALQUENCE · CARVYKTI · DARZALEX · DOPTELET · Da Vinci Surgical System · Doptelet · ELREXFIO · ENHERTU · EPKINLY · ERLEADA · Empaveli · Enhertu · FOTIVDA · FRUZAQLA · Fabhalta · GIVLAARI · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Itovebi · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · LIBTAYO · LONSURF · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · NINLARO · Nplate · Nubeqa · OGSIVEO · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Ogivri · Onivyde · Orserdu · PADCEV · PLUVICTO · PROMACTA · Phesgo · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · ROLVEDON · RYBREVANT · Rezlidhia · SARCLISA · SCEMBLIX · SUSTOL · TAGRISSO · TASIGNA · TECVAYLI · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Trelstar · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · Venclexta · XPOVIO · XTANDI · Xospata · Yescarta · ZEJULA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (73%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
4
Per 100K population
2.2
County median income
$71,931
Nearest hospital
MERCY MEDICAL CENTER REDDING
7.9 mi
7.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ravindran is a mixed practice specialist, with above-average Medicare volume (top 24% in CA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ravindran experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Ravindran performed 9,180 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ravindran receive payments from pharmaceutical companies?
Yes. Dr. Ravindran received a total of $11,716 from 60 companies across 342 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ravindran's costs compare to other hematology & oncology specialists in Redding?
Dr. Ravindran's average Medicare payment per service is $18. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ravindran) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Redding
Browse hematology & oncology specialists in Redding ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
Heron Therapeutics, Inc. Payments to Doctors
See all physicians who received payments from Heron Therapeutics, Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology